Edition:
United States

Celcuity Inc (CELC.OQ)

CELC.OQ on NASDAQ Stock Exchange Capital Market

18.11USD
8 Dec 2017
Change (% chg)

$0.12 (+0.67%)
Prev Close
$17.99
Open
$18.00
Day's High
$18.33
Day's Low
$17.78
Volume
7,553
Avg. Vol
--
52-wk High
$21.65
52-wk Low
$11.10

Chart for

About

Celcuity, Inc. is a cellular analysis company. The Company is focused on discovering new cancer sub-types and commercializing diagnostic tests designed to significantly improve the clinical outcomes of cancer patients treated with targeted therapies. The Company’s proprietary CELx diagnostic platform uses a patient’s living... (more)

Overall

Beta: --
Market Cap(Mil.): $182.59
Shares Outstanding(Mil.): 10.08
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 186.11 15.67
EPS (TTM): -- -- --
ROI: -- -11.32 34.62
ROE: -- -35.69 16.00

BRIEF-Celcuity reports Q3 loss $0.26/shr

* Celcuity reports third quarter fiscal 2017 financial results

Nov 13 2017

BRIEF-Celcuity announces pricing of initial public offering

* Celcuity Llc - ‍announced today pricing of its upsized IPO of 2,400,000 shares of its common stock at a public offering price of $9.50 per share​

Sep 20 2017

Earnings vs. Estimates